Since you requested further information.
From JAT's announcment (https://www.asx.com.au/asxpdf/20200203/pdf/44ds5s7prnyzvt.pdf):
"Sales of the Neurio lactoferrin brands in January 2020 amounted to $3.44 million. This compares to sales of $407,000 in January 2019. In the six months ended 31 December 2019, sales of all Neurio products was $9.4 million."
So they did 37% of the previous 6 month's sales in just one month. Certainly a positive sign for A2M indeed.
2019-nCOV, page-204
-
- There are more pages in this discussion • 489 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.45 |
Change
-0.010(0.15%) |
Mkt cap ! $4.669B | |||
| Open | High | Low | Value | Volume |
| $6.46 | $6.49 | $6.42 | $9.613M | 1.489M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1779 | $6.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.46 | 11650 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |